Menopausal hormone therapy use is associated with higher odds of high blood pressure, according to research published July 11 in the open access journal PLoS ONE. Longer hormone use was associated with further increased odds of high blood pressure, although this association decreased with subjects' ages.
The authors of the study, led by Joanne Lind of the University of Western Sydney, included 43,405 postmenopausal women in their study to identify the association.
As Dr. Lind explains, the study shows that "longer use of menopausal hormone therapy is associated with having high blood pressure. It is therefore important that high blood pressure be conveyed as a health risk for women considering using menopausal hormone therapy."
The results of the study may be taken into account when women are deciding whether, and for how long, menopausal hormone therapy is right for them.
Citation: Chiu CL, Lujic S, Thornton C, O'Loughlin A, Makris A, et al. (2012) Menopausal Hormone Therapy Is Associated with Having High Blood Pressure in Postmenopausal Women: Observational Cohort Study. PLoS ONE 7(7): e40260. doi:10.1371/journal.pone.0040260
Financial Disclosure: Dr. Lind is supported by a National Health and Medical Research Council (NHMRC) Fellowship (Australia). www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interest Statement:The authors have declared that no competing interests exist.
PLEASE LINK TO THE SCIENTIFIC ARTICLE IN ONLINE VERSIONS OF YOUR REPORT (URL goes live after the embargo ends): http://dx.plos.org/10.1371/journal.pone.0040260
Disclaimer: This press release refers to upcoming articles in PLoS ONE. The releases have been provided by the article authors and/or journal staff. Any opinions expressed in these are the personal views of the contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.
About PLoS ONE
PLoS ONE is the first journal of primary research from all areas of science to employ a combination of peer review and post-publication rating and commenting, to maximize the impact of every report it publishes. PLoS ONE is published by the Public Library of Science (PLoS), the open-access publisher whose goal is to make the world's scientific and medical literature a public resource.
All works published in PLoS ONE are Open Access. Everything is immediately available—to read, download, redistribute, include in databases and otherwise use—without cost to anyone, anywhere, subject only to the condition that the original authors and source are properly attributed. For more information about PLoS ONE relevant to journalists, bloggers and press officers, including details of our press release process and our embargo policy, see the everyONE blog at http://everyone.plos.org/media.